SCHEMBL22472575

SCHEMBL22472575

c1ccc2c(c1)nc1oc3cc(-c4ccc5c(n4)nc4sc6ccccc6n45)ccc3n12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.37
KDM4E B2RXH2 4/20 0.37
NPC1 O15118 3/20 0.37
HSD17B10 Q99714 2/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 1/20 0.37
POLB P06746 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
APEX1 P27695 2/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 4/20 0.32
ALDH1A1 P00352 3/20 0.32
PDE1B Q01064 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
THRB P10828 2/20 0.32
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16432493 0.70 SMN1; SMN2 (0.66) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL30282194 0.70 SMN1; SMN2 (0.66) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL18701360 0.69 RAB9A (0.41) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL22472569 0.67 KDM4E (0.35) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL17491659 0.67 NPC1 (0.66) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL17491667 0.67 NPC1 (0.48) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL16441936 0.67 SMN1; SMN2 (0.35) RAB9AKDM4ENPC1HSD17B10LMNA
SCHEMBL22472373 0.66 KDM4E (0.36) RAB9AKDM4ENPC1HSD17B10TP53
SCHEMBL20041419 0.65 NPC1 (0.40) RAB9AKDM4ENPC1HSD17B10TP53
SCHEMBL16441916 0.64 PIK3CD (0.47) RAB9AKDM4ENPC1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10790455-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10790455-B2 Organic electroluminescent materials and devices ORC3, ALKBH2, ENPP3 RAB9A 2730/4885KDM4E 1498/4885NPC1 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.